インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • サイテファクター
  • コスモスIF
  • シマゴ
  • ウルリッヒの定期刊行物ディレクトリ
  • 電子ジャーナルライブラリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • 雑誌の抄録索引作成ディレクトリ
  • OCLC-WorldCat
  • プロクエスト召喚
  • 学者の舵取り
  • 仮想生物学図書館 (vifabio)
  • パブロン
  • ジュネーブ医学教育研究財団
  • Google スカラー
このページをシェアする
ジャーナルチラシ
Flyer image

概要

The interaction of p53 and MDM2 genes in cancers, in silico studies and phylogenetic analysis

Jayaraman A, Jamil K, Raju S

The normal cell cycle process is a crucial process and is generally mediated by a number of regulatory genes. One of the most important regulators is the tumor suppressor p53, which in turn is regulated by MDM2 gene. The expression of p53 and MDM2 is found to be frequently altered in many cancers and metastasis/ relapses .This is the first report to look at the evolutionary history of these genes to decipher the role of these genes in the tumorigenesis process using in silico methods. We also found that they showed high degree of sequence similarity across the mammalian species, indicating that these species probably share parallel cancer causing mechanisms. Their individual unrooted phylogenetic tree formed 5 clusters each; however, p53 gene was found in a large number of species whereas MDM2 was found in smaller number of species. The role of MDM2 is therefore limited and occurs in fewer species across the mammalian species. It is evident that these molecules play an important role in the cancer process, perhaps responsible for relapses and hence need to be explored further as therapeutic targets. Such studies that are based on evidence from paleontology and genetics suggest that mechanisms of cancer are embedded deeply throughout evolution. Understanding the phylogenetic evolution of these genes could help in furthering our knowledge on the mechanisms involved in cancer.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません